department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tnkase · pharmadog

pharmadog
drugs
Tnkase

drug

patient view →

tenecteplase

Marketedupdated 2mo ago

by Genentech Inc

Approved

community read0 votes

all catalysts(1)

phase 3 completion · 1

phase 3 completion

Government Stanley Medical College Hospital — tenecteplase (Phase III Trial Completion)

News(0)

no news has mentioned this drug yet

brand

Tnkase

generic

tenecteplase

indication

Acute Ischemic Stroke

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 3

tagNephrology2 co-mentions · 1 sources
companyGovernment Stanley Medical College Hospital1 co-mentions · 1 sources
tagInfectious Disease1 co-mentions · 1 sources

Trials studying tenecteplase

phase3Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancyterminatedn=20
phase3A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Wellrecruitingn=1,325
phase3Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Strokenot yet recruitingn=488
phase2Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomyrecruitingn=20
phase2Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Strokeenrolling by invitationn=40
phase1Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dosenot yet recruitingn=20
phase3Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENTrecruitingn=466
phase3Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Strokerecruitingn=398

more trials →